Imaging of Inflamed Carotid Artery Atherosclerotic Plaques with the Use of 99mTc-HYNIC-IL-2 Scintigraphy in End-stage Renal Disease Patients
Overview
Nuclear Medicine
Radiology
Authors
Affiliations
Purpose: Identification of vulnerable plaques remains crucial for better cardiovascular risk assessment. At least 20% of inflammatory cells within unstable (vulnerable) plaques comprise T lymphocytes, which contain receptors for interleukin-2 (IL-2); those receptors can be identified by scintigraphy with radiolabelled IL-2.The aim of this study was to identify the "inflamed" (vulnerable) plaques by scintigraphy using IL-2 labelled with (99m)Tc in the selected, high cardiovascular risk group of end-stage renal disease (ESRD) patients.
Methods: A total of 28 patients (18 men, 10 women, aged 55.2 ± 9.6 years, 17 on peritoneal dialysis, 11 on haemodialysis) underwent common carotid artery (CCA) scintigraphy with the use of (99m)Tc-hydrazinonicotinamide (HYNIC)-IL-2. In all cases, ultrasound examination of the CCA was performed and levels of selected proinflammatory factors, atherogenic markers and calcium-phosphate balance parameters were measured. Finally, the target to non-target (T/nT) ratio of IL-2 uptake in atherosclerotic plaques with intima-media thickness (IMT), classic cardiovascular risk factors and concentrations of the measured factors were compared.
Results: Increased (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques in 38/41 (91%) cases was detected. The median T/nT ratio of focal (99m)Tc-HYNIC-IL-2 uptake in atherosclerotic plaques was 2.35 (range 1.23-3.63). The mean IMT value on the side of plaques assessed by scintigraphy was 0.79 ± 0.18 mm (median 0.8, range 0.5-1.275). Correlations between T/nT ratio and homocysteine (R = 0.22, p = 0.037), apolipoprotein B (apoB) (R = 0.31, p = 0.008), apoB to apoA-I ratio (R = 0.29, p = 0.012) and triglyceride concentration (R = 0.26, p = 0.021) were detected. A lower T/nT ratio in patients with better parameters of nutritional status (haemoglobin, albumin, adiponectin) in comparison with patients with worse nutritional parameters (3.20 ± 0.5 vs 2.16 ± 0.68, p = 0.025) was revealed as well as a difference between values of T/nT ratio in groups of patients with values of apoB, soluble CD40 ligand and asymmetric dimethylarginine above and below median (3.18 ± 0.52 vs 2.16 ± 0.68, p = 0.031). No statistically significant association was found between T/nT ratio and mean value of either IMT or classic cardiovascular risk factors.
Conclusion: Scintigraphy with the use of (99m)Tc-HYNIC-IL-2 can be a tool for inflamed atherosclerotic (vulnerable) plaque visualization within CCA in ESRD patients. Quantitative results of carotid artery scintigraphy with (99m)Tc-HYNIC-IL-2 correlate with serum concentration of selected cardiovascular risk markers.
Present status and future trends in molecular imaging of lymphocytes.
Lauri C, Varani M, Bentivoglio V, Capriotti G, Signore A Semin Nucl Med. 2022; 53(1):125-134.
PMID: 36150910 PMC: 9489269. DOI: 10.1053/j.semnuclmed.2022.08.011.
CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease.
Zhang S, Breidenbach J, Russell B, George J, Haller S J Clin Med. 2020; 9(11).
PMID: 33202988 PMC: 7697100. DOI: 10.3390/jcm9113653.
Radiotracers used for the scintigraphic detection of infection and inflammation.
Tsopelas C ScientificWorldJournal. 2015; 2015:676719.
PMID: 25741532 PMC: 4337049. DOI: 10.1155/2015/676719.
Imaging atherosclerosis and risk of plaque rupture.
Osborn E, Jaffer F Curr Atheroscler Rep. 2013; 15(10):359.
PMID: 23982263 PMC: 3816112. DOI: 10.1007/s11883-013-0359-z.